Oxymorphone Hydrochloride Tablet
Product Images NDC 31722-930

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Oxymorphone Hydrochloride (NDC 31722-930). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

10 mg 100 Ct

10 mg 100 Ct
This is a description of a medication named Oxymorphone Hydrochloride. The medication comes in tablet form and each tablet is of 10 mg strength. The medication guide should be dispensed separately to each patient. The recommended storage temperature is between 20°C to 25°C. The medication is equipped with a child-resistant closure. The manufacturer of the medication is Camber Pharmaceuticals, located in Piscataway, NJ, and it is manufactured by Ascent Pharmaceuticals, located in Central Islip, NY. The usual dosage information is provided in the insert.*
FDA Label Image

5 mg 100 Ct

5 mg 100 Ct
Oxymorphone Hydrochloride is a prescription medication that comes in the form of Tablets, USP containing 5 mg of Oxymorphene Hydsochlaride, USP each. It is advised to refer to the package insert for complete prescribing information before using this medicine. This medication should be stored in a dry and cool place between 20°C-25°C (68°F-77°F). The medication should only be dispensed with the medication guide provided to each patient. It should be dispensed in a container defined in the USP with a child-resistant closure. The bottle opening seal should not be broken or missing. This medication is manufactured by Ascent Bharmaceuticals, Inc. in Central Islip, NY 11723, and is manufactured for Camber Phagmaceuticals, Inc in Piscataway, NJ 08834.*
FDA Label Image

Structure

Structure
FDA Label Image

Table 2

Table 2
This text contains warnings and precautions for the use of Oxymorphone Hydrochloride in combination with alcohol, benzodiazepines, central nervous system depressants, serotonergic drugs, muscle relaxants, diuretics, and anticholinergic drugs. The concomitant use of these drugs may lead to respiratory depression, sedation, coma, and potential overdose. It is advised to monitor patients closely for signs of respiratory depression and sedation and to adjust dosages accordingly. The use of naloxone for the emergency treatment of opioid overdose is recommended. Cimetidine may potentiate respiratory depression in combination with Oxymorphone Hydrochloride.*
FDA Label Image

Table 1

Table 1
This is a table showing the percentage of adverse reactions reported in placebo-controlled trials with Oxymorphone Hydrochloride Tablets. Adverse reactions reported include nausea, pyrexia, somnolence, vomiting, pruritus, headache, dizziness (excluding vertigo), constipation, and confusion. The number of participants in the trials are also listed.*
FDA Label Image

Table 3

Table 3

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.